Adherence variable | Participants who received VL assessments N = 165 | VL ≥ 1000 copies/mL N = 12 (7.3) | VL < 1000 copies/mL N = 153 (92.7) | aOR (95%CI) | P-value |
---|---|---|---|---|---|
Pharmacy refill | |||||
Low adherence | 17 (10.3) | 6/17 (35.3) | 11/17 (64.7) | 14.4 (3.8–54.8) | 0.0001 |
Moderate adherence | 11 (6.7) | 1/11 (9.1) | 10/11 (90.9) | 2.6 (0.3–24.8) | 0.395 |
High adherence | 137 (83.0) | 5/137 (3.6) | 132/137 (96.4) | 1 | |
Self-report | |||||
Low adherence | 7 (4.2) | 4/7 (57.1) | 3/7 (42.9) | 21.2 (4.0–111.2) | 0.0003 |
Moderate adherence | 25 (15.2) | 2/25 (8.0) | 23/25 (92.0) | 1.4 (0.3–6.9) | 0.695 |
High adherence | 133 (80.6) | 6/133 (4.5) | 127/133 (95.5) | 1 | |
VAS | |||||
Low adherence | 18 (10.9) | 9/18 (50.0) | 9/18 (50.0) | 124.0 (14.1–1090.4) | < 0.0001 |
Moderate adherence | 22 (13.3) | 2/22 (9.1) | 20/22 (90.9) | 12.4 (1.1–143.0) | 0.06 |
High adherence | 125 (75.8) | 1/125 (0.8) | 124/125 (99.2) | 1 | |
CAS | |||||
Low adherence | 17 (10.3) | 8/17 (47.1) | 9/17 (52.9) | 7.6 (1.8–30.8) | 0.005 |
Moderate adherence | 38 (23.0) | 4/38 (10.5) | 34/38 (89.5) | 1 | |
High adherence | 110 (66.7) | 0 (0.0) | 110/110 (100) | – |